Connect
← Return to Newly diagnosed stage 2. Trying to decide on a treatment plan.
Discussion
Newly diagnosed stage 2. Trying to decide on a treatment plan.
Prostate Cancer | Last Active: 7 hours ago | Replies (12)Comment receiving replies
Putting your biopsy in this forum would give us a lot more information about what your situation is. Just knowing you are a great group 2, is not enough. How many cores were taken and how many of them had at least a 3+3 or higher?.
Were any of these things found in the biopsy intraductal, ductal, large cribriform, Seminal vesicle invasion, EPE or ECE. (Extraprostatic extensions extra capsular extensions). They can make the cancer much more aggressive.
Because you got prostate cancer so young, you should get a hereditary genetic test. If there is cancer in your family, it’s even more important. Breast cancer, Prostate cancer, Pancreatic cancer and other cancer can be due to genetics. I got prostate cancer at 62 because I have a genetic problem. My brother got it at 77 because he doesn’t, But we both have a father that died from prostate cancer, Another serious problem, resulting in more than doubling the chance that we could get it.
Replies to "Putting your biopsy in this forum would give us a lot more information about what your..."
Connect
Sorry, new to this still getting my bearings. My gleason was 3 + 4 and my Decipher Genomic score was 0.18. PSA 2.4, clinical stage T2a. I believe the Dr did 20 core samples total. I've had a PET and no other cancer was found elsewhere. I don't know the answers to your other questions, but I'll inquire.
MRI results:
1. Vague area of mild diffusion abnormality in the LEFT peripheral zone at the mid gland towards the apex without suspicious enhancement, indeterminate.
2. Prostate gland volume of 20 cc.
3. No pelvic lymphadenopathy or suspicious osseous lesions.
Total PI-RADS score: 3 - Intermediate (the presence of clinically significant cancer is equivocal)
Narrative
3/21/2026 7:21 AM
HISTORY/REASON FOR EXAM: Prostate cancer
TECHNIQUE/EXAM DESCRIPTION:
MRI of the prostate without and with contrast.
The study was performed on a Philips 3.0 Tesla MRI scanner.
Sagittal and axial T2; oblique high resolution axial and coronal T2; oblique axial diffusion-weighted imaging and ADC map with B values of 100, 400, and 1000; oblique axial dynamic postcontrast images of the prostate; postcontrast T1 fat-sat sequence of
the pelvis.
1 mg of glucagon was administered intravenously prior to the exam.
20 mL ProHance contrast was administered intravenously.
COMPARISON: 8/10/2023
FINDINGS:
The prostate measures 3.4 x 2.7 x 4.2 cm with a volume of 20 cc. Prostate density is 0.11.
Peripheral zone: Tiny T1 hyperintense focus in the RIGHT peripheral zone toward the apex. Several ill-defined areas of mild to moderate T2 hypointensity, consistent with sequela of prostatitis.
Transitional zone: Stromal and glandular nodules.
Prostate lesions:
Lesion #1:
Location: Left peripheral midgland (PZpl)
Size: 0.6 cm
Capsular involvement: Lesion abuts the capsule. No seminal vesicle invasion.
DWI/ADC score: 3
Enhancement: "-"
Total PI-RADS score: 3
The bladder is normal in appearance.
No adenopathy is identified.
No suspicious bony lesions are identified.